9 May 2024 - acquisition
We last commented on Abingdon Health in March at the time of the interim results in which the company reported a doubling of revenue and a significant reduction in losses. At the time we suggested the shares were a speculative buy and so it is pleasing they have moved up since then. The company has announced that it has extended its activities and expertise in the regulatory environment with the acquisition of IVDeology Holdings (IVD) for consideration of up to £700,000. The first £500,000 has been satisfied through the issue of 5m shares to . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
